Ranbaxy Announces Settlement of Possible Imitrex(R) Litigation With GlaxoSmithKline
PRINCETON, N.J., Jan. 21 (HSMN NewsFeed) -- Ranbaxy Laboratories Limited (Ranbaxy) announced today that it has settled all matters relating to possible patent litigation with GlaxoSmithKline relating to Sumatriptan Succinate Tablets, the generic version ... Biopharmaceuticals, Generics, LitigationRanbaxy Laboratories, GlaxoSmithKline, Sumatriptan, Imitrex (Source: HSMN NewsFeed)
Let Andrew Lansley's NHS medicine be put to the test
The Health Secretary has won the right to see his NHS reform Bill be given the chance to work, says Norman Tebbit. (Source: Telegraph Health)div id=medwormpbiMedWorm Message:/i/b Register forba href=http://www.medmatcha.com target =_selfMedMatcha, MedWorm's medical advertising network/a/b, and receive $5 free advertising./p/div
